Acurx Pharmaceuticals, Inc. ACXP Q4 2025 Annual earnings
Reported March 13, 2026 · Before market open
EPS-$0.31Beat by $0.70
EPS estimate-$1.01
Next report
Aug 14, 2026 (In 2 weeks)EPS estimate-$0.42
Versus estimates
Diluted EPS
Ask the moment Acurx Pharmaceuticals, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Acurx Pharmaceuticals, Inc. report Q4 2025 earnings?
- Acurx Pharmaceuticals, Inc. (ACXP) reported Q4 2025 earnings on March 13, 2026 before market open.
- What were Acurx Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?
- Acurx Pharmaceuticals, Inc. reported eps of $-0.31 for Q4 2025.
- Did Acurx Pharmaceuticals, Inc. beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-1.01 by $0.70.
- How did Acurx Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 93.8% from $-0.16.
- Where can I find Acurx Pharmaceuticals, Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001104659-26-027052) directly on SEC EDGAR. The filing index links above go to sec.gov.